Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation
Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies
Early Action, Better Outcomes: Transforming Cancer Prevention
Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Next Generation Armored Car T-Cell Therapy Trial Now Open
FDA Approves New Therapy for Glioma Patients for First Time in Decades
Liver Surgery: Minimally Invasive Techniques Can Be an Option
Dana-Farber Research Publication 8.01.2024
Johns Hopkins All Children’s Researchers Receive Florida Grants for Cancer Inquiries
Jennifer Leiding, M.D., Joins Cancer & Blood Disorders Institute
Rethinking Breast Cancer: Illuminating New Paths to Treatment and Prevention
Researchers Devise Novel Solution to Preventing Relapse after CAR T-cell Therapy
Can FDG-PET/CT Inform Neoadjuvant Therapy for Patients with HER2+ Breast Cancer?
Showing 121 - 135 of 1049 results
Previous| 1... 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
